Richard Burr, former US senator and current chair of DLA Piper’s Health Policy Strategic Consulting practice, talks with Julie Gerberding, former director of the U.S. Centers for Disease Control and Prevention (CDC) and current CEO of the Foundation for the National Institutes of Health (FNIH). The wide-ranging conversation includes thoughts on the Pandemic and All-Hazards Preparedness Act (PAHPA), lessons learned from COVID-19, and potential benefits of AI in therapeutic research and development.